NO892677L - Fremgangsmaate for fremstilling av 5-oxygenerte hmg-coa-reduktaseinhibitorer. - Google Patents

Fremgangsmaate for fremstilling av 5-oxygenerte hmg-coa-reduktaseinhibitorer.

Info

Publication number
NO892677L
NO892677L NO89892677A NO892677A NO892677L NO 892677 L NO892677 L NO 892677L NO 89892677 A NO89892677 A NO 89892677A NO 892677 A NO892677 A NO 892677A NO 892677 L NO892677 L NO 892677L
Authority
NO
Norway
Prior art keywords
coa reductase
hmg
reductase inhibitors
oxygenate
procedure
Prior art date
Application number
NO89892677A
Other languages
English (en)
Norwegian (no)
Other versions
NO892677D0 (no
Inventor
Mark E Duggan
George D Hartman
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US07/250,646 external-priority patent/US4921974A/en
Priority claimed from US07/322,398 external-priority patent/US4963538A/en
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Publication of NO892677D0 publication Critical patent/NO892677D0/no
Publication of NO892677L publication Critical patent/NO892677L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/16—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D309/28—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/30—Oxygen atoms, e.g. delta-lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02—Silicon compounds
    • C07F7/08—Compounds having one or more C—Si linkages
    • C07F7/18—Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
    • C07F7/1804—Compounds having Si-O-C linkages

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Hematology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Saccharide Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO89892677A 1988-06-29 1989-06-27 Fremgangsmaate for fremstilling av 5-oxygenerte hmg-coa-reduktaseinhibitorer. NO892677L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US21301088A 1988-06-29 1988-06-29
US07/250,646 US4921974A (en) 1988-09-29 1988-09-29 Intermediates and processes in the preparation of 5-oxygenated HMG-COA reductase inhibitors
US07/322,398 US4963538A (en) 1988-06-29 1989-03-13 5-oxygenated HMG-CoA reductase inhibitors

Publications (2)

Publication Number Publication Date
NO892677D0 NO892677D0 (no) 1989-06-27
NO892677L true NO892677L (no) 1990-01-02

Family

ID=27395805

Family Applications (1)

Application Number Title Priority Date Filing Date
NO89892677A NO892677L (no) 1988-06-29 1989-06-27 Fremgangsmaate for fremstilling av 5-oxygenerte hmg-coa-reduktaseinhibitorer.

Country Status (14)

Country Link
EP (1) EP0349063B1 (fr)
JP (1) JPH0253752A (fr)
KR (1) KR910000694A (fr)
AT (1) ATE127798T1 (fr)
AU (1) AU619563B2 (fr)
CA (1) CA1328876C (fr)
DE (1) DE68924205T2 (fr)
DK (1) DK319989A (fr)
FI (1) FI893004L (fr)
HU (1) HUT50803A (fr)
IL (1) IL90781A0 (fr)
NO (1) NO892677L (fr)
NZ (1) NZ229671A (fr)
PT (1) PT90958B (fr)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT88364A (pt) * 1987-09-02 1989-07-31 Merck & Co Inc Process for preparing novel hmg-coa reductase inhibitors
US5073568A (en) * 1988-11-14 1991-12-17 Hoffmann-La Roche Inc. Antipsoriatic agents
US5200549A (en) * 1988-11-14 1993-04-06 Hoffman-La Roche Inc. Antipsoriatic agents
CA2036962C (fr) * 1990-02-26 1998-09-15 Ann E. Decamp Methode de desilylation d'une 4-silyloxy-tetrahydropyran-2-one
US5059696A (en) * 1990-03-15 1991-10-22 Merck & Co., Inc. Processes and intermediates for the preparation of 5-oxygenated hmg-coa reductase inhibitors
MY106564A (en) * 1990-07-06 1995-06-30 Squibb & Sons Inc Sulfur-substituted mevinic acid derivatives.
US5286746A (en) * 1991-12-20 1994-02-15 E. R. Squibb & Sons, Inc. Sulfur-substituted mevinic acid derivatives
US5369123A (en) * 1992-10-09 1994-11-29 E. R. Squibb & Sons, Inc. Nitrogen-substituted mevinic acid derivatives useful as HMG-CoA reductase inhibitors
SI20159A (sl) * 1999-02-04 2000-08-31 LEK, tovarna farmacevtskih in kemi�nih izdelkov, d.d. Nov postopek za odstranitev sililoksi zaščitne skupine iz 4-sililoksi tetrahidro-piran-2-on-ov
SI21187A (sl) 2002-03-26 2003-10-31 Krka, Tovarna Zdravil D.D., Novo Mesto Postopek za pripravo 4-oksitetrahidropiran-2-onov
EP3698797A1 (fr) 2017-10-16 2020-08-26 Tsinghua University Inhibiteur de la voie de l'acide mévalonique et composition pharmaceutique correspondante

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS56150037A (en) * 1980-04-22 1981-11-20 Sankyo Co Ltd Hydronaphthalene compound
JPS58188872A (ja) * 1982-04-26 1983-11-04 Suntory Ltd オクタヒドロナフタレン誘導体及びその製造法
JPS59186972A (ja) * 1983-03-09 1984-10-23 Suntory Ltd オクタヒドロナフタレン誘導体並びにその製造法
US4668699A (en) * 1985-08-05 1987-05-26 Merck & Co., Inc. Novel HMG-CoA reductase inhibitors
PT85109A (en) * 1986-06-23 1987-07-01 Merck & Co Inc Process for the preparation of hydroxy-tetrahydropyranone derivatives or corresponding ring opened dihydroxy acids which are hmg-coa reductase inhibitors
PT88364A (pt) * 1987-09-02 1989-07-31 Merck & Co Inc Process for preparing novel hmg-coa reductase inhibitors

Also Published As

Publication number Publication date
NO892677D0 (no) 1989-06-27
FI893004A0 (fi) 1989-06-19
HUT50803A (en) 1990-03-28
DE68924205D1 (de) 1995-10-19
FI893004A7 (fi) 1989-12-30
IL90781A0 (en) 1990-01-18
DK319989A (da) 1990-01-02
ATE127798T1 (de) 1995-09-15
AU619563B2 (en) 1992-01-30
PT90958B (pt) 1994-11-30
EP0349063A3 (en) 1990-05-09
DE68924205T2 (de) 1996-03-28
AU3711689A (en) 1990-01-04
NZ229671A (en) 1991-11-26
CA1328876C (fr) 1994-04-26
KR910000694A (ko) 1991-01-30
EP0349063A2 (fr) 1990-01-03
FI893004L (fi) 1989-12-30
DK319989D0 (da) 1989-06-28
PT90958A (pt) 1989-12-29
EP0349063B1 (fr) 1995-09-13
JPH0253752A (ja) 1990-02-22

Similar Documents

Publication Publication Date Title
ES2101960T3 (es) Lactamas benzo-condensadas.
DK354189A (da) Fremgangsmaade til lactonisering af mevinsyreforbindelser
DK51087A (da) Antihypercholesterolaemiske forbindelser
NO901392D0 (no) Immunomodulerende azaspiraner.
ES2126697T3 (es) Inhibidores de enzimas de conversion de angiotensina que contienen lactamas de anillos multiples.
NO892677D0 (no) Fremgangsmaate for fremstilling av 5-oxygenerte hmg-coa-reduktaseinhibitorer.
FI935944A0 (fi) Pyratsolopyrimidin- samt pyrimidinylbisfosfonestrar som anti- inflammatorer
AU2623192A (en) Antifungal agent
ES2179254T3 (es) 1-poliarilpirazoles plaguicidas.
ES2087247T3 (es) Inhibidor de aldosa reductasa.
DE68904018D1 (de) Antihypercholesterolemische 4,5-diaryl-2-substituierte thioimidazole.
GR3007465T3 (fr)
EP0245003A3 (fr) Composés antihypercholestérolémiques
EP0245004A3 (fr) Composés antihypercholestérolémiques
DE69025817D1 (de) 3-Keto-HMG-CoA Reduktase-Inhibitoren
YU127289A (sh) INHIBITORI 5-OKSIGENISANE HMG-CoA REDUKTAZE
ITMI911855A1 (it) Procedimento per la preparazione di biciclo (3. 2. 0) ept-2-en-7-oni
ATE126816T1 (de) Polyzyklische farbstoffe.
FI911124A0 (fi) Nya pyridinderivat och foerfaranden foer deras syntetisering.
ATE110384T1 (de) Makrolid-derivate.
EP0264951A3 (en) Procaterol-derivatives